Old Web
English
Sign In
Acemap
>
authorDetail
>
A.‐M. O’Farrell
A.‐M. O’Farrell
Metformin
Endocrinology
Placebo
Type 2 diabetes
Diabetes mellitus
2
Papers
55
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial.
2010
Diabetes, Obesity and Metabolism
H. M. R. Pattzi
S. Pitale
M Alpizar
C. A. Bennett
A.‐M. O’Farrell
Jianke Li
Julie M. Cherrington
Hans-Peter Guler
Show All
Source
Cite
Save
Citations (30)
The dipeptidyl peptidase-4 inhibitor PHX1149 improves blood glucose control in patients with type 2 diabetes mellitus
2008
Diabetes, Obesity and Metabolism
G. Garcia‐Soria
G. Gonzalez‐Galvez
G. M. Argoud
M. Gerstman
Thomas W. Littlejohn
Sherwyn Schwartz
A.‐M. O’Farrell
Xinqiang Li
Julie M. Cherrington
C. A. Bennett
Hans-Peter Guler
Show All
Source
Cite
Save
Citations (25)
1